FLNA Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
0
0
Cost of Revenue
0
0
Gross Profit
0
0
Operating Expenses
9.4M
-15.9%
11.2M
R&D
3.3M
-27.3%
4.5M
SG&A
6.1M
-8.1%
6.6M
Operating Income
-9393000
+15.9%
-11168000
EBITDA
-9149000
+16.3%
-10925000
Net Income
-8603000
+16.7%
-10331000
EPS (Basic)
$-0.18
+14.3%
$-0.21
EPS (Diluted)
$-0.18
+14.3%
$-0.21
Shares (Diluted)
48.3M
-1.8%
49.2M
Filana Therapeutics (FLNA) โ€” Financials